RELAPSING-REMITTING MULTIPLE SCLEROSIS

Clinical trials for RELAPSING-REMITTING MULTIPLE SCLEROSIS explained in plain language.

Never miss a new study

Get alerted when new RELAPSING-REMITTING MULTIPLE SCLEROSIS trials appear

Sign up with your email to follow new studies for RELAPSING-REMITTING MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 4 Completed 5 Terminated 1

New MS injection for kids enters testing

Disease control Not yet recruiting

This study is testing a new under-the-skin injection version of the MS drug ocrelizumab in children and teenagers aged 10 to 18. The main goals are to see how the drug moves through the body, if it's safe, and how it affects the immune system. Participants will receive the drug f…

Matched conditions: RELAPSING-REMITTING MULTIPLE SCLEROSIS

Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RELAPSING-REMITTING MULTIPLE SCLEROSIS

Get alerted when new RELAPSING-REMITTING MULTIPLE SCLEROSIS trials appear

New MS injection for kids enters testing